6/2/23 19:15 | 6/2/23 | MRTX | Mirati Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Stelzer Laurie | CA | O | CFO | S | -172 | 37.06 | 0 | -5 | -5 | 80 | D | | | | | | | | | | | | | | |
4/2/21 20:10 | 3/16/21 | ARNA | Arena Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Stelzer Laurie | CA | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 13 | 547 | 15 | D | | | | | | | | | | | | | | |
2/24/20 20:03 | 2/22/20 | HALO | Halozyme Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Stelzer Laurie | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 11 | 10 | 126 | D | | | | | | | | | | | | | | |
2/18/20 16:15 | 2/14/20 | HALO | Halozyme Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Stelzer Laurie | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 8 | 7 | 119 | D | | | | | | | | | | | | | | |
2/13/20 18:38 | 2/12/20 | HALO | Halozyme Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Stelzer Laurie | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 11 | 11 | 114 | D | | | | | | | | | | | | | | |
2/4/20 16:21 | 2/3/20 | HALO | Halozyme Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Stelzer Laurie | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 23 | 28 | 107 | D | | | | | | | | | | | | | | |
6/17/19 08:19 | 6/15/19 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Stelzer Laurie | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 7 | 8 | 92 | D | | | | | | | | | | | | | | |
2/22/19 19:03 | 2/22/19 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Stelzer Laurie | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 11 | 15 | 88 | D | | | | | | | | | | | | | | |
2/15/19 17:33 | 2/14/19 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Stelzer Laurie | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 8 | 11 | 81 | D | | | | | | | | | | | | | | |
2/5/19 16:10 | 2/3/19 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Stelzer Laurie | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 23 | 44 | 76 | D | | | | | | | | | | | | | | |
6/18/18 16:23 | 6/15/18 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Stelzer Laurie | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 7 | 13 | 61 | D | | | | | | | | | | | | | | |
2/23/18 17:13 | 2/22/18 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Stelzer Laurie | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 11 | 25 | 58 | D | | | | | | | | | | | | | | |
2/5/18 16:25 | 2/3/18 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Stelzer Laurie | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 23 | 86 | 50 | D | | | | | | | | | | | | | | |
6/16/17 16:10 | 6/15/17 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Stelzer Laurie | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 7 | 24 | 35 | D | | | | | | | | | | | | | | |
2/6/17 19:01 | 2/3/17 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Stelzer Laurie | CA | O | SVP,CFO | M.d | 0 | 0.00 | 29 | 23 | 297 | 31 | D | -11 | 48 | 20 | 47 | 14 | 8 | 4 | 6 | 0 | 1 | 4 | 14 | | |
6/16/16 16:12 | 6/15/16 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Stelzer Laurie | CA | O | SVP,CFO | M.d | 0 | 0.00 | 14 | 7 | 69 | 17 | D | -11 | -56 | -41 | 12 | -9 | -10 | -5 | 3 | -6 | -5 | -2 | 22 | 21 | |
8/26/15 14:22 | 8/20/15 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Stelzer Laurie | CA | O | CFO | P.a | 172 | 17.24 | 33 | 10 | New | 10 | I | 125 | 74 | 11 | -5 | -28 | -28 | -12 | -2 | 3 | -2 | 4 | 4 | -54 | -44 |
8/24/15 08:46 | 8/20/15 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Stelzer Laurie | CA | O | CFO | P | 172 | 17.24 | 33 | 10 | New | 10 | I | 139 | 84 | 12 | -1 | -26 | -25 | -13 | -9 | -3 | 6 | 0 | -2 | -55 | -41 |